Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Introduction: In relapsing Multiple Sclerosis (RMS) patients treated with disease modifying drugs (DMDs), few data are available regarding the biomarkers of treatment response. We aimed to assess the predictive value of lymphocyte count (LC) and Body Mass Index (BMI) for treatment response in a real...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Manni, Alessia, Iaffaldano, Antonio, Lucisano, Giuseppe, D'Onghia, Mariangela, Mezzapesa, Domenico Maria, Felica, Vincenzo, Iaffaldano, Pietro, Trojano, Maria, Paolicelli, Damiano
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587065/
https://ncbi.nlm.nih.gov/pubmed/31258529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01343
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados